Land: New Zealand
Sprog: engelsk
Kilde: Medsafe (Medicines Safety Authority)
Fluphenazine decanoate 25 mg/mL (26.88mg added to provide 25mg/ml plus a 7.5% excess.)
Bristol-Myers Squibb (NZ) Limited
Fluphenazine decanoate 25 mg/mL (26.88mg added to provide 25mg/ml plus a 7.5% excess.)
25 mg/mL
Injection (depot)
Active: Fluphenazine decanoate 25 mg/mL (26.88mg added to provide 25mg/ml plus a 7.5% excess.) Excipient: Benzyl alcohol Nitrogen Sesame oil
Ampoule, glass, 1ml One Point Cut ampoule, 5 dose units
Prescription
Prescription
Fine Chemicals Corporation (Pty) Limited
Fluphenazine decanoate is indicated in the long-term management of psychotic disorders including schizophrenia, mania and organic brain syndrome. It is of particular value in the treatment of chronic schizophrenia and for patients who are unreliable at taking oral medication. The drug often alleviates such target symptoms as hallucinations, delusions, confusion and withdrawal. It is not only useful in the hospital milieu but is unparalleled, because of its long duration of action in the long-term maintenance therapy of chronically psychotic patients who are amenable to out-patient therapy. Fluphenazine decanoate has not been shown to be effective in the management of behavioural complications in patients with mental retardation.
Package - Contents - Shelf Life: Ampoule, glass, 1ml One Point Cut ampoule - 5 dose units - 18 months from date of manufacture stored at or below 25°C protect from light. Do not refrigerate or freeze - Ampoule, glass, 0.5ml One Point Cut ampoule - 5 dose units - 18 months from date of manufacture stored at or below 25°C protect from light. Do not refrigerate or freeze
1971-01-14
NZ_Modecate__ V8.0 27 February 2013 1 DATA SHEET NAME OF MEDICINE Modecate Modecate Concentrate Fluphenazine decanoate PRESENTATION Injection: Straw-coloured viscous liquid containing fluphenazine decanoate 12.5mg/0.5mL and 25mg/mL; 100mg/mL (Concentrate); in a sesame oil vehicle, with benzyl alcohol as preservative. USES ACTIONS Fluphenazine decanoate is an esterified trifluoromethyl phenothiazine derivative. Chemically, fluphenazine is 4-(3-[2-(Trifluoromethyl) phenothiazin-10-y1]propyl)-1 piperazine. It is a highly potent antipsychotic agent with a markedly extended duration of action, available for intramuscular administration. The basic effects of fluphenazine decanoate appear to be no different from those of fluphenazine hydrochloride. The only exception to this is a prolonged duration of action. The esterification of fluphenazine with decanoic acid markedly prolongs the drug's duration of effect without reducing its activity. Like all phenothiazine derivatives, fluphenazine decanoate appears to act on the hypothalamus, depressing various components of the mesodiencephalic activating system which is involved in the control of basal metabolism and body temperature, wakefulness, vasomotor tone, emesis, and hormonal balance. In addition, the phenothiazines exert a peripheral autonomic affect to varying degrees. However, the site and mode of action of the phenothiazines have not been completely elucidated. NZ_Modecate__ V8.0 27 February 2013 2 Fluphenazine and its ester derivatives differ from other phenothiazines in several respects; fluphenazine and its esters are more potent on a milligram basis, appear to be less sedating, and have less potentiating effect on central nervous system depressants and anaesthetics than do some of the other Læs hele dokumentet